Logo

Call us today 212-583-0100

ir@enzo.com    

  • Home
  • Corporate
    • Investor Information
    • About Us
    • Officers & Directors
    • Press Releases
    • Careers
  • Therapeutics
    • About ENZO Therapeutics
      • Overview
      • Our Mission
      • Our Strategy
      • Partnering
      • Maps and Directions
      • Contact Us
    • Therapeutic Market
      • Overview
      • Inflammatory Bowel Disease
      • Uveitis
      • HIV
      • Bone Disorders
      • Diabetes
    • Technologies
      • Immune Regulation
      • Gene Technology
      • Cell Signaling Modulation
    • Pipeline
      • Overview
      • Cell Signaling Modulation
        • Diabetes
        • Preclinical Studies for Bone Disorders
      • Immune Regulation
        • Alequel ™
        • Optiquel ™
      • Gene Technology
        • Stealth Vector™ HGTV43™
  • Clinical Labs
  • Life Sciences
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Oct 15, 2009 8:15am EDT

Enzo Biochem's Life Sciences Subsidiary Unveils Comprehensive Menu of Epigenetics Tools at Society for Neurosciences Meeting

Oct 14, 2009 4:33pm EDT

Enzo Biochem Reports Record Fiscal 2009 and Fourth Quarter Revenues

Oct 13, 2009 9:32am EDT

Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Year-End 2009 Results for October 15, 2009, at 8:30 AM E.T.

Oct 07, 2009 9:00am EDT

Enzo Biochem's Life Sciences Division Introduces a Rapid, No-Wash Apoptosis Assay for Cytotoxicity Screening

Oct 01, 2009 11:42am EDT

Enzo Biochem Life Science Unit and BioTek Instruments Form Strategic Collaboration to Provide Innovative System for the Study of Live Cells

Sep 21, 2009 7:36am EDT

Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo's Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis

Sep 18, 2009 8:00am EDT

Dr. Kevin Krenitsky, President of Enzo Clinical Labs, to Present At 27th Annual Lab Institute

Sep 17, 2009 8:00am EDT

Enzo Biochem's Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components

Sep 16, 2009 8:00am EDT

Enzo Biochem to Present at UBS Global Life Sciences Conference

Sep 09, 2009 8:00am EDT

Enzo Biochem to Present at Thomas Weisel Partners 2009 Healthcare Conference

  • Previous
  • 1…
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next
RSS
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Meta

  • Privacy Policy
  • Intellectual Property
  • Safe Harbor Statement
  • HIPAA Policy
  • Web Feedback

Contact us

Enzo Biochem Executive Offices
81 Executive Blvd, Suite 3
Farmingdale, NY
11735
USA

212-583-0100

info@enzo.com

Copyright ©2023 Enzo Biochem Inc.